TSHA
USDTaysha Gene Therapies Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$4.290
Máximo
$4.540
Mínimo
$4.000
Volumen
5.02M
Fundamentos de la Empresa
Capitalización de Mercado
1.2B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
6.14M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Raymond James Initiates Coverage On Taysha Gene Therapies with Strong Buy Rating, Announces Price Target of $13
Raymond James analyst Christopher Raymond initiates coverage on Taysha Gene Therapies with a Strong Buy rating and announces Price Target of $13.
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies
Acciones Relacionadas
MGNX
MacroGenics Inc.
EHC
Encompass Health Corporation
SWN
Southwestern Energy Company
SRG
Seritage Growth Properties
RZC
Reinsurance Group of America Incorporated 7.125% Fixed-Rate Reset Subordinated Debentures due 2052
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.